Coexistence of Neurofibromatosis Type 1 and Male Breast Cancer.


Journal

Archives of Iranian medicine
ISSN: 1735-3947
Titre abrégé: Arch Iran Med
Pays: Iran
ID NLM: 100889644

Informations de publication

Date de publication:
01 Nov 2021
Historique:
received: 11 01 2021
accepted: 28 04 2021
entrez: 29 11 2021
pubmed: 30 11 2021
medline: 15 12 2021
Statut: epublish

Résumé

Breast cancer is one of the rarest types of cancer in men. Its incidence increases with age, as in women. Neurofibromatosis type 1 is an autosomal dominant genetic disease that predisposes to many cancer types. Neurofibromatosis and breast cancer have been more frequently distinguished and better studied in women. Characteristically, estrogen, progesterone receptors, negative, and overexpression of human epidermal growth factor receptor 2 (HER2) are detected in patients with female neurofibromatosis breast cancers. In cases reported so far, estrogen and progesterone receptors have been evaluated as positive and HER2 negative in male patients. With the high possibility of breast cancer development in female patients with neurofibromatosis at an earlier age, prompt and careful evaluation is required in terms of both examination and radiological imaging. Unfortunately, there are no thorough recommendations for breast cancer follow-up in male patients with neurofibromatosis. Here, we present a breast cancer, which is an uncommon type of cancer in male neurofibromatosis.

Identifiants

pubmed: 34841831
doi: 10.34172/aim.2021.126
doi:

Substances chimiques

Biomarkers, Tumor 0
Receptors, Estrogen 0
Receptors, Progesterone 0
Receptor, ErbB-2 EC 2.7.10.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

852-855

Informations de copyright

© 2021 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Auteurs

Baris Mantoglu (B)

Sakarya University Teaching and Research Hospital Department of General Surgery/ Sakarya, Turkey.

Burak Kamburoglu (B)

Sakarya University Teaching and Research Hospital Department of General Surgery/ Sakarya, Turkey.

Ismail Zengin (I)

Bozuyuk State Hospital Department of General Surgery Bilecik, Turkey.

Kayhan Ozdemir (K)

Sakarya University Teaching and Research Hospital Department of General Surgery/ Sakarya, Turkey.

Ebru Kayra (E)

Sakarya University School of Medicine Department of Pathology Sakarya, Turkey.

Emre Gonullu (E)

Sakarya University Teaching and Research Hospital Department of General Surgery/ Sakarya, Turkey.

Fatih Altintoprak (F)

Sakarya University School of Medicine Department of General Surgery/ Sakarya, Turkey.

Belma Kocer (B)

Sakarya University School of Medicine Department of General Surgery/ Sakarya, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH